Epic SCIENCES’ CTC-based liquid-biops... - Advanced Prostate...

Advanced Prostate Cancer

21,056 members26,262 posts

Epic SCIENCES’ CTC-based liquid-biopsy test for AR-V7

podsart profile image
5 Replies

Wondering if anyone had any interaction/knowledge of EPIC Sciences regarding this test.

What the requirements for approval/payment by medicare/medicare advantage patients? What does it cost? Do they have a "surprise billing protection provision like Guardant360 has?

Is there a minimal PSA level needed to make this test valid?

Of those that have used it, how "actionable" were the findings; under what conditions?

Written by
podsart profile image
podsart
To view profiles and participate in discussions please or .
Read more about...
5 Replies
Tall_Allen profile image
Tall_Allen

Why do you want it? Why not just try Zytiga?

podsart profile image
podsart in reply to Tall_Allen

Discussed with Dr Drake using the Guardant360 to see what genetically changed if the 5/31/22 1st non detectable Psa since Feb 2016 is confirmed/increased. Dr Drake said that a CTC-ARV7 test would be more actionable.

He also said insurance has become more difficult. Guardant has a "surprise bill process" , so if after insurance is addressed, they will call you if the bill looks bigger than $100 before they proceed, so you dont suddenly end up with a bill in the thousands $$. I was wondering re cost of ARV7 cost and whether they have such a "surprise bill" opt out.

Understand frequently resistance to Xtandi is related to a mutation of the AR, so CTC-ARV7 test made sense.

I read that if Xtandi resistance is reached, there is high degree of cross resistance to Zytiga. I have some memory that an AR mutation would also affect Zytiga. However, he did say he would consider trying Zytiga if the next test showed confirmation and/or progression. He also mused about Chemo as well.. In the meantime he said to go to full dose 4 pills/day from my current very low dose of 3 pill per week.

Thanks

Tall_Allen profile image
Tall_Allen in reply to podsart

From what I've read, AR-V7 is a fairly rare mutation at the start, but increases with hormone therapy use. There are many other causes of resistance. Since tests are expensive, it seems easier to just try the drug and see if it works.

podsart profile image
podsart in reply to Tall_Allen

Understand; thank you

podsart profile image
podsart

Thanks -- not sure how to research the "skepticism" of EPIC's test; however, I will try a google search [perhaps google scholar as well].

I will look into if Foundation One Medicine has a blood draw AR-V7 analysis.

Thanks

You may also like...

AR-V7 - CTC's - Risk of Death

nd-epic-sciences-shows-only-nuclear-localized-ar-v7-is-predictive-of-therapy-benefit-for-patients-wi

Doctor refuses to test for AR-V7

AR-V7 test. The doctor says that since hubby progressed on both Abiraterone and Xtandi the test is...

Oncotype DX AR-V7 Test Approved for Coverage by Medicare

This is a sort of important test. Especially if you start becoming castration-resistant, which...

\"New Normal\" AR-v7 Questions

the second AR-v7 patient his MO has had...what questions do we ask to help him out? What does the...

overall survival time with Ar-v7

I'm trying to find the reality of what the near future may look like with Ar-v7. (Bone scan is...